News

Awards were presented at the School of Medicine Awards Ceremony on May 19th.

Congratulations to seven students in the pharmacology and molecular cancer biology PhD programs who graduated on Sunday, May 11, 2025. They were among 442 students from the Duke University School of Medicine who graduated, marking the successful culmination of their hard work and dedication.

Read the full story here: https://medschool.duke.edu/blog/ashley-colemon-phd-molecular-cancer-biology 

Spotlight on Shane Killarney, MD, PhD, School of Medicine graduating class of 2025.

Synovial sarcoma is a rare, aggressive soft tissue cancer with few effective treatment options, which means patients often have a poor prognosis.

A study published in the journal Cell from Hui-Kuan Lin and colleagues could help revive drugs once considered too big to work.

A breast cancer drug approved in 2023 that was identified in the lab of Donald McDonnell, PhD, is helping women with late-stage breast cancer.

Jude Raj, a graduate student in the lab of Kris Wood, PhD, received the Paul and Lauren Ghaffari Graduate Fellowship, which provides support to doctoral students pursuing oncology-related research.

A multi-faceted study from Department of Pharmacology and Cancer Biology researchers shows for the first time that blocking an under-studied enzyme called PKN2 may be the key to stopping aggressive, treatment-resistant cancers.

The Distinguished Neurotoxicologist Award recognizes those "who have made important, high-impact scientific, regulatory, or service contributions" to Neurotoxicology.